Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2012

Neptune Technologies and Bioressources, Inc. (NEPT) to Present at the ROTH Capital Partners 24th Annual Conference

Neptune Technologies and Bioressources is a recognized industry leader in innovation, production, and formulation of science-based and clinically proven novel phospholipid products for the nutraceutical and pharmaceutical markets. Neptune focuses on expanding consumer health markets – such as cardiovascular, inflammatory, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Matador Resources Co. (MTDR) Reports 2012 Operating and Financial Data

Matador Resources disclosed operational data on its oil and gas activities, as well as provided financial guidance on the company’s capital budget for 2012. Matador Resources has set the company’s capital budget for this year at approximately $313 million, with … Continue reading

Posted in Small Cap News | Leave a comment

Golfsmith International Holdings, Inc. (GOLF) Opens Cutting-Edge Store in Chattanooga

Golfsmith International Holdings, Inc., the largest specialty golf retailer in the country, is set to open an experiential golf store in Chattanooga in time for the coming golf season. The company’s latest store, boasting 15,750 square feet, will provide golfers … Continue reading

Posted in Small Cap News | Leave a comment

NeuLion, Inc. (NLN) to Present at the ROTH Capital Partners 24th Annual Conference

NeuLion is the true end-to-end technology service provider for the delivery of live and on-demand content to any Internet-enabled device. Founded in 2000, the company empowers content owners and distributors, cable operators, and telecommunications companies to capitalize on the enormous … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Neurocrine Biosciences, Inc. (NBIX) to Present at the ROTH Capital Partners 24th Annual Conference

Neurocrine Biosciences is a biopharmaceutical company with its focus on neurological and endocrine diseases and disorders. The company’s product candidates address some of the biggest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

NeurogesX, Inc. (NGSX) to Present at the ROTH Capital Partners 24th Annual Conference

NeurogesX is a specialty pharmaceutical company engaged in the development and commercialization of a portfolio of novel non-opioid pain management therapies. The company’s lead product, Qutenza – currently approved in the U.S. and the E.U. – is now available in … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

New York Mortgage Trust, Inc. (NYMT) to Present at the ROTH Capital Partners 24th Annual Conference

New York Mortgage Trust is a real estate investment trust, or REIT, engaged in the acquisition, investment, financing, and management of assets that are chiefly mortgage-related. These financial assets include agency and non-agency residential mortgage-backed securities, high credit quality residential … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Noah Education Holdings Ltd. (NED) to Present at the ROTH Capital Partners 24th Annual Conference

Noah Education Holdings is a leader in providing education services in China. Noah’s brands include Wentai Education, an operator and manager of high-end kindergartens, primary, and secondary schools; Little New Star, which offers English language training in its directly owned … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Nova Measuring Instruments, Ltd. (NVMI) to Present at the ROTH Capital Partners 24th Annual Conference

Nova Measuring Instruments is a leading global developer, producer, and marketer of advanced integrated and standalone metrology solutions for the semiconductor manufacturing industry. Nova’s metrology products are complemented by advanced structure modeling and application development software that empowers fab engineers … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

NovaBay Pharmaceuticals, Inc. (NBY) to Present at the ROTH Capital Partners 24th Annual Conference

NovaBay Pharmaceuticals is an advanced clinical-stage biotechnology company engaged in developing two distinct categories of product offerings. The company’s aim is to address the significant unmet therapeutic needs of the worldwide anti-infective market. The company’s first-in-class Aganocide compounds are patented … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment